川恆股份(002895.SZ):放棄福泉川東增資優先認繳出資權
格隆匯 3 月 8日丨川恆股份(002895.SZ)公佈,公司參股子公司貴州福泉川東化工有限公司(“福泉川東”)為解決業務發展所需資金,擬通過股東進行增資擴股。福泉川東控股股東重慶川東化工(集團)有限公司(“重慶川東”)擬以現金方式對福泉川東增資2億元。公司根據業務發展規劃,將放棄福泉川東此次增資優先認繳出資權,不參與此次增資。此次增資完成後,福泉川東註冊資本將由2億元增加至4億元,公司對福泉川東持股比例由15%降至7.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.